Christine Bestvina

Assistant Professor

University of Chicago Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christine Bestvina is an Assistant Professor at the University of Chicago Medicine, USA. Her research primarily focuses on oncology, particularly exploring immunotherapy, lung cancer treatments, and predictive biomarkers in cancer patients. Recent articles include studies on EGFR/TGF-β signaling, the efficacy of Durvalumab combined with radiation, and the impact of circulating tumor DNA in early-stage lung cancer.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Everett E. Vokes

University of Chicago

UNITED STATES

View details

Marina Garassino

Università degli Studi di Torino

ITALY

View details

Gregory Gan

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

Hania Al-Hallaq

Emory University

UNITED STATES

View details

Sherin Rouhani

University of Chicago

UNITED STATES

View details

Natalia Issaeva

Assistant Profeessor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Jun Zhang

Associate Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christine Bestvina

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Bridging EGFR/TGF-β signaling to bypass resistance to immune checkpoint blockade

DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.

Combined RET and MEK Inhibition as a Treatment for RET Fusion-Positive NSCLC With Acquired BRAF Fusion: A Case Report

Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal

Immunotherapy partners after progression: Right place, right time?

COVID-19 Outcomes, Patient Vaccination Status, and Cancer-Related Delays during the Omicron Wave: A Brief Report from the TERAVOLT Analysis

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy.

A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study)

Severity of COVID-19 in patients with lung cancer: evidence and challenges.

Anaplastic Lymphoma Kinase Mutation-Positive Non-Small Cell Lung Cancer.

Collaborators (7)

Everett E. Vokes

Marina Garassino

Gregory Gan

Hania Al-Hallaq

Sherin Rouhani

Natalia Issaeva

Jun Zhang

Make your next move.